Boan Biotech (06955) signed a promotion cooperation agreement with Nanjing Luye

Zhitongcaijing · 1d ago

Zhitong Finance App News, Boan Biotech (06955) announced that on October 9, 2026, the company signed a promotion cooperation agreement with Nanjing Luye (a subsidiary of Luye Pharmaceutical (the controlling shareholder of the Company)). Nanjing Luye will provide promotion and marketing services for the company's designated products for the period from October 9, 2026 to September 30, 2027.

The Group currently has five marketed products and is implementing a commercialization strategy, focusing on expanding product coverage, strengthening market access and improving product penetration through a mature distribution network composed of more than 154 dealers and more than 3,210 target hospitals. The Company believes that by entering into a promotion cooperation agreement, the Group will be able to use Nanjing Luye's marketing expertise and resources to enhance the market penetration and brand awareness of its products. The promotion and marketing services to be provided by Nanjing Luye will support the Group's commercialization strategy for biosimilar drugs and biological products, and are expected to help increase the Group's revenue from products.